Free Preview
It’s the first of the month -- a big day in the 7investing universe -- and we’re really excited about our March picks. We’ll celebrate by talking about the new Johnson & Johnson single-dose vaccine that the FDA just approved and we’lll look at whether it makes any sense to move into “recovery” stocks as the economy begins to move more toward normal. The answer isn’t simple and it probably isn’t what you;re hearing elsewhere.
